Your browser doesn't support javascript.
loading
Insufficiency of non-canonical PRC1 synergizes with JAK2V617F in the development of myelofibrosis.
Shinoda, Daisuke; Nakajima-Takagi, Yaeko; Oshima, Motohiko; Koide, Shuhei; Aoyama, Kazumasa; Saraya, Atsunori; Harada, Hironori; Rahmutulla, Bahityar; Kaneda, Atsushi; Yamaguchi, Kiyoshi; Furukawa, Yoichi; Koseki, Haruhiko; Shimoda, Kazuya; Tanaka, Tomoaki; Sashida, Goro; Iwama, Atsushi.
Affiliation
  • Shinoda D; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Nakajima-Takagi Y; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Oshima M; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Koide S; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Aoyama K; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Saraya A; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Harada H; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Rahmutulla B; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Kaneda A; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Yamaguchi K; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Furukawa Y; Laboratory of Oncology, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • Koseki H; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Shimoda K; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Tanaka T; Division of Clinical Genome Research, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Sashida G; Division of Clinical Genome Research, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Iwama A; Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Leukemia ; 36(2): 452-463, 2022 02.
Article in En | MEDLINE | ID: mdl-34497325
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Differentiation / Janus Kinase 2 / Primary Myelofibrosis / Polycomb Repressive Complex 1 / Mutation Type of study: Etiology_studies Limits: Animals Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Differentiation / Janus Kinase 2 / Primary Myelofibrosis / Polycomb Repressive Complex 1 / Mutation Type of study: Etiology_studies Limits: Animals Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Type: Article Affiliation country: Japan